Working… Menu

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AKCEA-TTR-LRx in Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03728634
Recruitment Status : Completed
First Posted : November 2, 2018
Last Update Posted : March 13, 2020
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.